{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:07:39Z","timestamp":1779782859648,"version":"3.53.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05585-5","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:38:03Z","timestamp":1777045083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating Angiopoietin-1\/Angiopoietin-2 ratio may reflect pre- and post-treatment vascular states in Glioblastoma and improve discrimination between tumor recurrence and radiation necrosis"],"prefix":"10.1007","volume":"177","author":[{"given":"Filippo","family":"Gagliardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3330-162X","authenticated-orcid":false,"given":"Pierfrancesco","family":"De Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Roncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Snider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Boselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Di Terlizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"4","key":"5585_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1750-3639.2005.tb00115.x","volume":"15","author":"I Fischer","year":"2005","unstructured":"Fischer I et al (2005) Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol 15(4):297\u2013310","journal-title":"Brain Pathol"},{"issue":"4","key":"5585_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1750-3639.2005.tb00116.x","volume":"15","author":"Y Reiss","year":"2005","unstructured":"Reiss Y, Machein MR, Plate KH (2005) The role of angiopoietins during angiogenesis in gliomas. Brain Pathol 15(4):311\u2013317","journal-title":"Brain Pathol"},{"key":"5585_CR3","doi-asserted-by":"publisher","first-page":"e18761429386400","DOI":"10.2174\/0118761429386400250415053351","volume":"17","author":"G Lv","year":"2024","unstructured":"Lv G et al (2024) Regulatory Mechanisms of STAT3 in GBM and its Impact on TMZ Resistance. Curr Mol Pharmacol 17:e18761429386400","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"5585_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","volume":"26","author":"D Liao","year":"2007","unstructured":"Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26(2):281\u2013290","journal-title":"Cancer Metastasis Rev"},{"issue":"49","key":"5585_CR5","doi-asserted-by":"publisher","first-page":"19611","DOI":"10.1073\/pnas.1117773108","volume":"108","author":"DR Wise","year":"2011","unstructured":"Wise DR et al (2011) Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 108(49):19611\u201319616","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"5585_CR6","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1016\/j.febslet.2008.06.033","volume":"582","author":"JL Lin","year":"2008","unstructured":"Lin JL et al (2008) Hypoxia-inducible factor-1alpha regulates matrix metalloproteinase-1 activity in human bone marrow-derived mesenchymal stem cells. FEBS Lett 582(17):2615\u20132619","journal-title":"FEBS Lett"},{"issue":"6","key":"5585_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/labinvest.3780088","volume":"80","author":"D Zagzag","year":"2000","unstructured":"Zagzag D et al (2000) Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 80(6):837\u2013849","journal-title":"Lab Invest"},{"issue":"5422","key":"5585_CR8","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","volume":"284","author":"J Holash","year":"1999","unstructured":"Holash J et al (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284(5422):1994\u20131998","journal-title":"Science"},{"issue":"43","key":"5585_CR9","doi-asserted-by":"publisher","first-page":"30896","DOI":"10.1074\/jbc.274.43.30896","volume":"274","author":"N Jones","year":"1999","unstructured":"Jones N et al (1999) Identification of Tek\/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274(43):30896\u201330905","journal-title":"J Biol Chem"},{"issue":"13","key":"5585_CR10","doi-asserted-by":"publisher","first-page":"9102","DOI":"10.1074\/jbc.275.13.9102","volume":"275","author":"A Papapetropoulos","year":"2000","unstructured":"Papapetropoulos A et al (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt\/survivin pathway. J Biol Chem 275(13):9102\u20139105","journal-title":"J Biol Chem"},{"issue":"5322","key":"5585_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC et al (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322):55\u201360","journal-title":"Science"},{"issue":"5","key":"5585_CR12","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0002-9440(10)65733-1","volume":"153","author":"A Stratmann","year":"1998","unstructured":"Stratmann A, Risau W, Plate KH (1998) Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153(5):1459\u20131466","journal-title":"Am J Pathol"},{"issue":"2","key":"5585_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/exnr.1999.7162","volume":"159","author":"D Zagzag","year":"1999","unstructured":"Zagzag D et al (1999) In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 159(2):391\u2013400","journal-title":"Exp Neurol"},{"issue":"4","key":"5585_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/01.ATV.21.4.536","volume":"21","author":"E Audero","year":"2001","unstructured":"Audero E et al (2001) Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies. Arterioscler Thromb Vasc Biol 21(4):536\u2013541","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5585_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3171\/2008.6.17612","volume":"110","author":"M Sie","year":"2009","unstructured":"Sie M et al (2009) The angiopoietin 1\/angiopoietin 2 balance as a prognostic marker in primary glioblastoma multiforme. J Neurosurg 110(1):147\u2013155","journal-title":"J Neurosurg"},{"issue":"2","key":"5585_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10014-024-00481-0","volume":"41","author":"T Ezaki","year":"2024","unstructured":"Ezaki T et al (2024) Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain Tumor Pathol 41(2):61\u201372","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"5585_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3171\/2009.5.JNS081074","volume":"112","author":"N Rafat","year":"2010","unstructured":"Rafat N et al (2010) Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg 112(1):43\u201349","journal-title":"J Neurosurg"},{"issue":"5","key":"5585_CR18","first-page":"647","volume":"3","author":"P Salven","year":"1997","unstructured":"Salven P et al (1997) Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 3(5):647\u2013651","journal-title":"Clin Cancer Res"},{"issue":"2\u20133","key":"5585_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/CBM-130310","volume":"14","author":"R Chiorean","year":"2014","unstructured":"Chiorean R et al (2014) Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: correlations with clinical data. Cancer Biomark 14(2\u20133):185\u2013194","journal-title":"Cancer Biomark"},{"issue":"1","key":"5585_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/neuonc\/noq170","volume":"13","author":"M Crocker","year":"2011","unstructured":"Crocker M et al (2011) Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor. Neuro Oncol 13(1):99\u2013108","journal-title":"Neuro Oncol"},{"issue":"1","key":"5585_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-010-0290-x","volume":"102","author":"G Reynes","year":"2011","unstructured":"Reynes G et al (2011) Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol 102(1):35\u201341","journal-title":"J Neurooncol"},{"issue":"3","key":"5585_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7150\/jca.104759","volume":"16","author":"S Kim","year":"2025","unstructured":"Kim S et al (2025) Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation. J Cancer 16(3):802\u2013811","journal-title":"J Cancer"},{"issue":"9","key":"5585_CR23","first-page":"2185","volume":"56","author":"S Takano","year":"1996","unstructured":"Takano S et al (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56(9):2185\u20132190","journal-title":"Cancer Res"},{"issue":"1","key":"5585_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s004010051199","volume":"100","author":"G Stockhammer","year":"2000","unstructured":"Stockhammer G et al (2000) Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. Acta Neuropathol 100(1):101\u2013105","journal-title":"Acta Neuropathol"},{"issue":"5","key":"5585_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/neuonc\/nos307","volume":"15","author":"N Verma","year":"2013","unstructured":"Verma N et al (2013) Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol 15(5):515\u2013534","journal-title":"Neuro Oncol"},{"issue":"918","key":"5585_CR26","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1259\/bjr\/15169876","volume":"77","author":"N Lyubimova","year":"2004","unstructured":"Lyubimova N, Hopewell JW (2004) Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. Br J Radiol 77(918):488\u2013492","journal-title":"Br J Radiol"},{"issue":"5","key":"5585_CR27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/neuonc\/noac193","volume":"25","author":"P Karschnia","year":"2023","unstructured":"Karschnia P et al (2023) Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro Oncol 25(5):940\u2013954","journal-title":"Neuro Oncol"},{"issue":"33","key":"5585_CR28","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","volume":"41","author":"PY Wen","year":"2023","unstructured":"Wen PY et al (2023) RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol 41(33):5187\u20135199","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05585-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:59:29Z","timestamp":1779782369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05585-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5585"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05585-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the regional ethics committee (EC, LOMBARDIA 1; protocol NCH02-2022) and conducted in accordance with the Declaration of Helsinki. Clinicaltrial.gov registration: NCT05831631.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}